Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86/JN.1 and EG.5.1/HK.3Yuanchen Liu, Hin Chu, Feifei Liu et al.|Nature Communications|2024Cited by 46
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Hin Chu, Jingxin Qiao et al.|Nature Communications|2025Cited by 8
An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHin Chu, Shengyong Yang, Huiping Shuai et al.|Research Square|2024Cited by 1
Author Correction: An orally available Mpro/TMPRSS2 bispecific inhibitor with potent anti-coronavirus efficacy in vivoHuiping Shuai, Hin Chu, Jingxin Qiao et al.|Nature Communications|2025Cited by 0
YL1004 is a SARS-CoV-2 papain-like protease inhibitor with immunomodulatory and antiviral activity in miceJinshan Nan, Shengyong Yang, Huiping Shuai et al.|Nature Communications|2026Cited by 0